Joseph D. Barritt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joseph D. Barritt has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso De Simone
Department of Pharmacy, University of Naples Federico II, Naples, Italy
2 shared publications - Daniel G. Bracewell
Department of Biochemical Engineering University College London London UK
2 shared publications - Sarah L. Rouse
Department of Life Sciences, Imperial College London, London, United Kingdom
2 shared publications - Adriano Aguzzi
Institute of Neuropathology, University of Zürich, Zürich, Switzerland
1 shared publication - Alessandra Bigi
Department of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence, Italy
1 shared publication Alexander D. Cameron
University of Warwick
1 shared publication
Latest Publications
- Open Access
- 6 October 2026
- Published by Wiley in Biotechnology and Bioengineering
Cryo‐EM Analysis of Adenovirus Vector Reveals Purification Conditions Leading to Loss of Viral Fiber Proteins and Reduced Infectivity
Vaccines and gene therapies require efficient delivery of genetic material to host cells. Viral vectors leverage viruses' ability to enter host cells to achieve this. Following the SARS‐CoV‐2 vaccine and novel gene therapies that utilize adenovirus vectors, there has been an increase in the demand for large‐scale production of vectors. A benefit of adenovirus vectors is that they can act as a “plug and play” tool for any future emerging diseases for the development of vaccines. A key obstacle was the heterogeneity that is found in the final product. This can reduce the functionality of the vector and affect immune responses. A possible origin of heterogeneity is the downstream processing, specifically the bind and elute steps of anion exchange chromatography (AEX), which is widely used at scale. To better understand the heterogeneity that AEX could elicit on the adenovirus capsid, cryogenic‐electron tomography was used to assess the capsid integrity after a variety of chromatography conditions in comparison to a cesium chloride (CsCl) gradient ultracentrifugation purified control. To investigate the effect of absorption time during chromatography, AEX conditions with a 5, 10, and 20 min on‐resin absorption periods were evaluated. Following AEX binding at pH 6.5, samples showed a reduction from 17% in the CsCl purified control to 10% infectious particles. When examined using electron microscopy, the virions exhibited aggregation and a decrease from 70% to 54% in fiber occupancy. After a 20 min AEX hold at pH 6.5 there was almost complete loss of infectivity and fiber occupancy decreased from ~70% to below 30%. Samples run at pH 8 did not show the same loss in infectivity when held bound for 20 min. This suggests that purification conditions can cause removal of the fiber protein, which was likely causing the decrease in infectivity, due to the fiber's role in cell entry. We hypothesize that fiber removal was caused by a combination of hold time and weakened binding between the fiber and penton base due to the low pH conditions that are often used during AEX. This work demonstrates a link between fiber loss and reduced adenovirus vector functionality and how purification conditions can impact vector functionality. Through studying the relationship between structure and function, we can hopefully minimize loss of infectivity during purification by optimizing processing conditions, reduce manufacturing cost and improve the quality of adenovirus vaccines and gene therapies.
- 6 October 2026
- Published by Wiley in Biotechnology and Bioengineering
Open AccessCryo‐EM Analysis of Adenovirus Vector Reveals Purification Conditions Leading to Loss of Viral Fiber Proteins and Reduced Infectivity
Vaccines and gene therapies require efficient delivery of genetic material to host cells. Viral vectors leverage viruses' ability to enter host cells to achieve this. Following the SARS‐CoV‐2 vaccine and novel gene therapies that utilize adenovirus vectors, there has been an increase in the demand for large‐scale production of vectors. A benefit of adenovirus vectors is that they can act as a “plug and play” tool for any future emerging diseases for the development of vaccines. A key obstacle was the heterogeneity that is found in the final product. This can reduce the functionality of the vector and affect immune responses. A possible origin of heterogeneity is the downstream processing, specifically the bind and elute steps of anion exchange chromatography (AEX), which is widely used at scale. To better understand the heterogeneity that AEX could elicit on the adenovirus capsid, cryogenic‐electron tomography was used to assess the capsid integrity after a variety of chromatography conditions in comparison to a cesium chloride (CsCl) gradient ultracentrifugation purified control. To investigate the effect of absorption time during chromatography, AEX conditions with a 5, 10, and 20 min on‐resin absorption periods were evaluated. Following AEX binding at pH 6.5, samples showed a reduction from 17% in the CsCl purified control to 10% infectious particles. When examined using electron microscopy, the virions exhibited aggregation and a decrease from 70% to 54% in fiber occupancy. After a 20 min AEX hold at pH 6.5 there was almost complete loss of infectivity and fiber occupancy decreased from ~70% to below 30%. Samples run at pH 8 did not show the same loss in infectivity when held bound for 20 min. This suggests that purification conditions can cause removal of the fiber protein, which was likely causing the decrease in infectivity, due to the fiber's role in cell entry. We hypothesize that fiber removal was caused by a combination of hold time and weakened binding between the fiber and penton base due to the low pH conditions that are often used during AEX. This work demonstrates a link between fiber loss and reduced adenovirus vector functionality and how purification conditions can impact vector functionality. Through studying the relationship between structure and function, we can hopefully minimize loss of infectivity during purification by optimizing processing conditions, reduce manufacturing cost and improve the quality of adenovirus vaccines and gene therapies.
- Open Access
An octadecameric O- glucosyltransferase generates diversity in antibody epitopes on variant surface antigens in African trypanosomes
Immune evasion in many pathogens relies on sequence variation to generate antigenic diversity. African trypanosomes use an additional strategy where O -glucosylation of variant surface glycoproteins (VSGs) generates heterogeneous glycans that alter antibody epitope recognition, influencing infection outcome. However, the VSG O- glycosylation enzyme has remained unknown. Here, we identify ESAG3 as the glycosyltransferase required for generating these O- glycan-dependent epitopes. ESAG3 depletion in vivo abolishes O- glycosylation-specific monoclonal antibody recognition, while complementation restores binding. ESAG3 has strict UDP-glucose specificity, manganese dependence, and modifies serine/threonine residues within cysteine-flanked VSG peptides. Single-particle cryo-electron microscopy reveals that ESAG3 forms an unprecedented octadecameric architecture with C3 symmetry at 3.4 angstrom resolution, a novel quaternary organisation for a glycosyltransferase. Structure-guided mutagenesis demonstrates essential active-site residues for catalysis, while interface mutations disrupt octadecamer assembly and enhance substrate turnover, indicating that oligomeric architecture regulates catalytic output. This work establishes ESAG3 as a kinetoplastid-specific glucosyltransferase and reveals the molecular basis whereby VSG O -glycosylation generates epitope diversity alongside sequence-based antigenic variation. Significance statement: African trypanosomes evade host immunity by switching variant surface glycoproteins (VSGs) from a vast gene archive, generating extreme antigenic diversity through sequence polymorphism. O -glucosylation adds a second layer where heterogeneous O -linked sugars at the very top of surface-exposed VSG loops diversify the epitope space accessible to host antibodies. We identify ESAG3 as the O- glucosyltransferase responsible for this modification and reveal it forms an unprecedented 18-subunit architecture. Critically, ESAG3 is encoded within VSG expression sites, coupling O -glycosylation to monoallelic transcriptional control. When parasites switch expression sites, VSG sequence changes alongside co-transcribed O -glycosylation machinery, integrating genetic and chemical variation into a unified immune evasion strategy. This work provides the molecular and structural basis for O- glycan-mediated epitope control on the trypanosome surface.
Open AccessAn octadecameric O- glucosyltransferase generates diversity in antibody epitopes on variant surface antigens in African trypanosomes
Immune evasion in many pathogens relies on sequence variation to generate antigenic diversity. African trypanosomes use an additional strategy where O -glucosylation of variant surface glycoproteins (VSGs) generates heterogeneous glycans that alter antibody epitope recognition, influencing infection outcome. However, the VSG O- glycosylation enzyme has remained unknown. Here, we identify ESAG3 as the glycosyltransferase required for generating these O- glycan-dependent epitopes. ESAG3 depletion in vivo abolishes O- glycosylation-specific monoclonal antibody recognition, while complementation restores binding. ESAG3 has strict UDP-glucose specificity, manganese dependence, and modifies serine/threonine residues within cysteine-flanked VSG peptides. Single-particle cryo-electron microscopy reveals that ESAG3 forms an unprecedented octadecameric architecture with C3 symmetry at 3.4 angstrom resolution, a novel quaternary organisation for a glycosyltransferase. Structure-guided mutagenesis demonstrates essential active-site residues for catalysis, while interface mutations disrupt octadecamer assembly and enhance substrate turnover, indicating that oligomeric architecture regulates catalytic output. This work establishes ESAG3 as a kinetoplastid-specific glucosyltransferase and reveals the molecular basis whereby VSG O -glycosylation generates epitope diversity alongside sequence-based antigenic variation. Significance statement: African trypanosomes evade host immunity by switching variant surface glycoproteins (VSGs) from a vast gene archive, generating extreme antigenic diversity through sequence polymorphism. O -glucosylation adds a second layer where heterogeneous O -linked sugars at the very top of surface-exposed VSG loops diversify the epitope space accessible to host antibodies. We identify ESAG3 as the O- glucosyltransferase responsible for this modification and reveal it forms an unprecedented 18-subunit architecture. Critically, ESAG3 is encoded within VSG expression sites, coupling O -glycosylation to monoallelic transcriptional control. When parasites switch expression sites, VSG sequence changes alongside co-transcribed O -glycosylation machinery, integrating genetic and chemical variation into a unified immune evasion strategy. This work provides the molecular and structural basis for O- glycan-mediated epitope control on the trypanosome surface.
- Open Access
- 3 April 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (15) , 10537-10549
Structure–Toxicity Relationship in Intermediate Fibrils from α-Synuclein Condensates
The aberrant aggregation of α-synuclein (αS) into amyloid fibrils is associated with a range of highly debilitating neurodegenerative conditions, including Parkinson's disease. Although the structural properties of mature amyloids of αS are currently understood, the nature of transient protofilaments and fibrils that appear during αS aggregation remains elusive. Using solid-state nuclear magnetic resonance (ssNMR), cryogenic electron microscopy (cryo-EM), and biophysical methods, we here characterized intermediate amyloid fibrils of αS forming during the aggregation from liquid-like spherical condensates to mature amyloids adopting the structure of pathologically observed aggregates. These transient amyloid intermediates, which induce significant levels of cytotoxicity when incubated with neuronal cells, were found to be stabilized by a small core in an antiparallel β-sheet conformation, with a disordered N-terminal region of the protein remaining available to mediate membrane binding. In contrast, mature amyloids that subsequently appear during the aggregation showed different structural and biological properties, including low levels of cytotoxicity, a rearranged structured core embedding also the N-terminal region, and a reduced propensity to interact with the membrane. The characterization of these two fibrillar forms of αS, and the use of antibodies and designed mutants, enabled us to clarify the role of critical structural elements endowing intermediate amyloid species with the ability to interact with membranes and induce cytotoxicity.
- 3 April 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (15) , 10537-10549
Open AccessStructure–Toxicity Relationship in Intermediate Fibrils from α-Synuclein Condensates
The aberrant aggregation of α-synuclein (αS) into amyloid fibrils is associated with a range of highly debilitating neurodegenerative conditions, including Parkinson's disease. Although the structural properties of mature amyloids of αS are currently understood, the nature of transient protofilaments and fibrils that appear during αS aggregation remains elusive. Using solid-state nuclear magnetic resonance (ssNMR), cryogenic electron microscopy (cryo-EM), and biophysical methods, we here characterized intermediate amyloid fibrils of αS forming during the aggregation from liquid-like spherical condensates to mature amyloids adopting the structure of pathologically observed aggregates. These transient amyloid intermediates, which induce significant levels of cytotoxicity when incubated with neuronal cells, were found to be stabilized by a small core in an antiparallel β-sheet conformation, with a disordered N-terminal region of the protein remaining available to mediate membrane binding. In contrast, mature amyloids that subsequently appear during the aggregation showed different structural and biological properties, including low levels of cytotoxicity, a rearranged structured core embedding also the N-terminal region, and a reduced propensity to interact with the membrane. The characterization of these two fibrillar forms of αS, and the use of antibodies and designed mutants, enabled us to clarify the role of critical structural elements endowing intermediate amyloid species with the ability to interact with membranes and induce cytotoxicity.
- Open Access
- 21 December 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (4) , 974-984
Measurement of Adenovirus-Based Vector Heterogeneity
- 21 December 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 112 (4) , 974-984
Open AccessMeasurement of Adenovirus-Based Vector Heterogeneity
- Open Access
- 17 March 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (12)
Mechanism of misfolding of the human prion protein revealed by a pathological mutation
Significance: The misfolding and aggregation into amyloid fibrils of the prion protein (PrP) have been strongly linked with a group of neurodegenerative disorders that include the mad cow disease. Currently, the molecular origins of the prion diseases are unknown, including the underlying mechanisms of PrP misfolding and the regions promoting its aggregation. Here, we identified the structural basis by which the folded domain of the human PrP converts into amyloids. We showed that this process is promoted by intermediate species forming as a result of the pathological mutation T183A, and that POM antibodies are able to suppress completely the aggregation process by blocking the misfolding mechanism. This study thereby suggests possible molecular strategies to inhibit PrP aggregation into amyloids.
- 17 March 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (12)
Open AccessMechanism of misfolding of the human prion protein revealed by a pathological mutation
Significance: The misfolding and aggregation into amyloid fibrils of the prion protein (PrP) have been strongly linked with a group of neurodegenerative disorders that include the mad cow disease. Currently, the molecular origins of the prion diseases are unknown, including the underlying mechanisms of PrP misfolding and the regions promoting its aggregation. Here, we identified the structural basis by which the folded domain of the human PrP converts into amyloids. We showed that this process is promoted by intermediate species forming as a result of the pathological mutation T183A, and that POM antibodies are able to suppress completely the aggregation process by blocking the misfolding mechanism. This study thereby suggests possible molecular strategies to inhibit PrP aggregation into amyloids.
- Open Access
Structural and functional insights into the mechanism of action of plant boron transporters
Boron has essential roles in plant growth and development. BOR proteins are key in the active uptake and distribution of boron, and regulation of intracellular boron concentrations. However, their mechanism of action remains poorly studied. BOR proteins are members of the SLC4 family of transporters and thus homologues of well studied mammalian transporters including the human Anion Exchanger 1 (hAE1). Here we generated Arabidopsis thaliana BOR1 (AtBOR1) variants based i) on known disease causing mutations of hAE1 (S466R, A500R) and ii) a loss of function mutation (D311A) identified in the yeast BOR protein, ScBOR1p. The AtBOR1 variants express in yeast and localise to the plasma membrane, although both S466R and A500R exhibit lower expression than the WT AtBOR1 and D311A. The D311A, S466R and A500R mutations result in a loss of boron efflux activity in a yeast bor1p knockout strain. A. thaliana plants containing these three individual mutations exhibit substantially decreased growth phenotypes in soil under conditions of low boron. These data confirm an important role for D311 in the function of the protein and show that mutations equivalent to disease causing mutations in hAE1 have major effects in AtBOR1. We also obtained a low resolution cryo-EM structure of a BOR protein from Oryza sativa , OsBOR3 lacking the 30 C-terminal amino acids. This structure confirms the gate and core domain organisation previously observed for related proteins, and is strongly suggestive of an inward facing conformation.
Open AccessStructural and functional insights into the mechanism of action of plant boron transporters
Boron has essential roles in plant growth and development. BOR proteins are key in the active uptake and distribution of boron, and regulation of intracellular boron concentrations. However, their mechanism of action remains poorly studied. BOR proteins are members of the SLC4 family of transporters and thus homologues of well studied mammalian transporters including the human Anion Exchanger 1 (hAE1). Here we generated Arabidopsis thaliana BOR1 (AtBOR1) variants based i) on known disease causing mutations of hAE1 (S466R, A500R) and ii) a loss of function mutation (D311A) identified in the yeast BOR protein, ScBOR1p. The AtBOR1 variants express in yeast and localise to the plasma membrane, although both S466R and A500R exhibit lower expression than the WT AtBOR1 and D311A. The D311A, S466R and A500R mutations result in a loss of boron efflux activity in a yeast bor1p knockout strain. A. thaliana plants containing these three individual mutations exhibit substantially decreased growth phenotypes in soil under conditions of low boron. These data confirm an important role for D311 in the function of the protein and show that mutations equivalent to disease causing mutations in hAE1 have major effects in AtBOR1. We also obtained a low resolution cryo-EM structure of a BOR protein from Oryza sativa , OsBOR3 lacking the 30 C-terminal amino acids. This structure confirms the gate and core domain organisation previously observed for related proteins, and is strongly suggestive of an inward facing conformation.